Gem Aromatics Intrinsic Value
Gem Aromatics (GEMAROMA) median intrinsic value is ₹323.56 from 4 valuation models (range ₹107–₹473), vs current price ₹189.23 — +71.0% upside (Trading Below Calculated Value), margin of safety 41.5%. For current market price and key ratios, visit Gem Aromatics share price today.
GEMAROMA Valuation Methods Summary — DCF, Graham Number & P/E
Gem Aromatics intrinsic value across 4 models vs current price ₹189.23 — upside/downside and value range per method. Browse Gem Aromatics annual reports for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹315.56 | ₹284.00 - ₹347.12 | +66.8% | Book Value/Share: ₹315.56, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹323.56 | ₹291.20 - ₹355.92 | +71.0% | Revenue/Share: ₹404.44, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹106.67 | ₹96.00 - ₹117.34 | -43.6% | EBITDA: ₹16.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹473.07 | ₹378.46 - ₹567.68 | +150.0% | CF Growth: 15.0%, Discount: 15% |
GEMAROMA Intrinsic Value vs Market Price — All Valuation Models
Gem Aromatics fair value range ₹107–₹473 vs current market price ₹189.23 across 4 valuation models. Compare with Gem Aromatics valuation methods to assess whether the stock is under or overvalued.
GEMAROMA Intrinsic Value Analysis — Undervalued or Overvalued?
Gem Aromatics median intrinsic value ₹323.56, current price ₹189.23 — Trading Below Calculated Value by 71.0%, margin of safety 41.5%.
What is the intrinsic value of GEMAROMA?
Based on our comprehensive analysis using 4 different valuation methods, the estimated intrinsic value of Gem Aromatics (GEMAROMA) is ₹323.56 (median value). With the current market price of ₹189.23, this represents a +71.0% variance from our estimated fair value.
The valuation range spans from ₹106.67 to ₹473.07, indicating ₹106.67 - ₹473.07.
Is GEMAROMA undervalued or overvalued?
Based on our multi-method analysis, Gem Aromatics (GEMAROMA) appears to be trading below calculated value by approximately 71.0%.
GEMAROMA Financial Health — Key Ratios vs Industry Benchmarks
Gem Aromatics financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 4.83 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | -4.2% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 3.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.68x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
GEMAROMA Cash Flow Quality — Operating & Free Cash Flow
Gem Aromatics operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-25 Cr | ₹-72 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹40 Cr | ₹15 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹15 Cr | ₹6 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹-5 Cr | ₹-13 Cr | Negative Cash Flow | 3/10 |